Invitation – Inquiry into ADF use of Mefloquine and Tafenoquine

22 Jun 2018

The Senate


ADF use of Mefloquine and Tafenoquine

On 19 June 2018 the Senate referred to the Foreign Affairs, Defence and Trade References Committee a range of matters relating to the ADF use of Mefloquine and Tafenoquine for inquiry and report by 17 September 2018.

The full terms of reference are to inquire with particular reference to:

(a) the current and past policies and practices for:
(i) prescribing Quinoline anti-malarial drugs to ADF personnel, and
(ii) identifying and reporting adverse drug reactions from Quinoline anti-malarial drugs among ADF personnel;

(b) the nature and extent of any adverse health effects of those who have taken Mefloquine/Tafenoquine on serving and former ADF personnel;

(c) the support available for partners, carers and families of personnel who experience any adverse health effects of Quinoline anti-malarial drugs;

(d) a comparison of international evidence/literature available on the impact of Quinoline anti-malarials;

(e) how other governments have responded to claims regarding Quinoline anti-malarials; and

(f) any other related matters.

The purpose of this letter of invitation is to draw your attention to the inquiry and to invite you or your organisation to make a written submission to the committee by 31 July 2018.

There is no requirement to address the full terms of reference and you may choose to comment only on the terms of reference that are of relevance to you.

The committee prefers to receive submissions online as an attached document by accessing the committee website and selecting the Upload Submission Online link at .
Alternatively, submissions may be emailed as an attached document to [email protected] or mailed to the address below:
Committee Secretary
Senate Foreign Affairs, Defence and Trade References Committee
PO Box 6100
Parliament House
Canberra ACT 2600

Information relating to Senate committee inquiries, including notes to assist in the preparation of submissions for a committee, can be located at .

Submissions become committee documents and are made public only after a decision by the committee. Publication of submissions includes loading them onto the internet and making them available to other interested parties including the media. Please indicate if you wish the committee to consider keeping your submission, or part thereof, confidential.

The committee will consider all submissions, and may invite individuals and organisations to give evidence at a public hearing. Should you require further information, please contact the committee secretariat on (02) 6277 3535.

Yours sincerely

Lyn Beverley
Committee Secretary